Dose and fractionation schedules in radiotherapy for non-small cell lung cancer.
Ontology highlight
ABSTRACT: In the field of radiotherapy (RT), the issues of total dose, fractionation, and overall treatment time for non-small cell lung cancer (NSCLC) have been extensively investigated. There is some evidence to suggest that higher treatment intensity of RT, when given alone or sequentially with chemotherapy (CHT), is associated with improved survival. However, there is no evidence that the outcome is improved by RT at a higher dose and/or higher intensity when it is used concurrently with CHT. Moreover, some reports on the combination of full dose CHT with a higher biological dose of RT warn of the significant risk posed by such intensification. Stereotactic body radiotherapy (SBRT) provides a high rate of local control in the management of early-stage NSCLC through the use of high ablative doses
SUBMITTER: Kepka L
PROVIDER: S-EPMC8107746 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA